Toll-Like Receptors: Cost or Benefit for Cancer?
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1081-1090
Author(s):
T. Matijevic and J. Pavelic
Peptide Antagonist of the Androgen Receptor
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1106-1113
Author(s):
Wenqing Gao
Metabolic Targets of Cardiac HormonesTherapeutic Anti-Cancer Effects
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1159-1166
Author(s):
David L. Vesely
High Throughput Screening of Normal and Neoplastic Tissue Samples
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
13
Page:
253-267
Author(s):
Heidi S. Erickson, Gallya Gannot, Michael A. Tangrea, Rodrigo F. Chuaqui, John W. Gillespie and Michael R. Emmert-Buck
DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
Journal:
Current Molecular Medicine
Volume:
10
Page:
123-132
Author(s):
N. Shivapurkar and A. F. Gazdar
Tumor Markers: The Potential of “Omics” Approach
Journal:
Current Molecular Medicine
Volume:
10
Page:
249-257
Author(s):
M. Sikaroodi, Y. Galachiantz and A. Baranova
ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
127-134
Author(s):
S. Micuda, D. Rosel, A. Ryska and J. Brabek
Inhibitors of HDACs - Effective Drugs Against Cancer?
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
210-228
Author(s):
S. Muller and O. H. Kramer
The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
242-267
Author(s):
M. Hingorani, C. Spitzweg, G. Vassaux, K. Newbold, A. Melcher, H. Pandha, R. Vile and K. Harrington
How and Why to Screen for CYP2D6 Interindividual Variability in Patients Under Pharmacological Treatments
Journal:
Current Drug Metabolism
Volume:
11
Page:
276-282
Author(s):
Manuela De Gregori, Massimo Allegri, Simona De Gregori, Giulia Garbin, Carmine Tinelli, Mario Regazzi, Stefano Govoni and Guglielmina Nadia Ranzani